ResearcherNanfang HospitalNo recent work listed
Mengwan Wu
Matched on OpenAlex author ID A5000387149.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2016: 1 paper · 2017: none · 2018: 1 paper
Papers 2
- Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.bulcan.2017.10.028↗
- The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. First author DOI 10.1007/s13277-016-5122-y↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Jing Guo · 2 shared papers, 2016–2018
- Paper Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pan… DOI 10.1016/j.bulcan.2017.10.028↗
- Paper The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. DOI 10.1007/s13277-016-5122-y↗
- Qiang Zuo · 2 shared papers, 2016–2018
- Paper Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pan… DOI 10.1016/j.bulcan.2017.10.028↗
- Paper The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. DOI 10.1007/s13277-016-5122-y↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.